There are ongoing efforts to study the combination of EGFR inhibitors together with ICI (NCT03944941), and meanwhile, previous studies have shown that the combination of cytotoxic chemotherapy and ICI is effective for other cancer types [9, 11, 12]. The gene discussed is EGFR; the disease is cancer.